In the current month, AVNS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AVNS average Analyst price target in the last month is 14.000.
Based on analysts' estimates, AVNS EPS is projected to reach 0.163 in FY2026Q2, following reported EPS of 0.110 in FY2026Q1. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 0.11, while Avanos Medical IncAVNS's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD 0.16.